» Articles » PMID: 29791595

MicroRNA-3129 Promotes Cell Proliferation in Gastric Cancer Cell Line SGC7901 Via Positive Regulation of PRb

Overview
Date 2018 May 24
PMID 29791595
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Several microRNAs (miRNAs) have been reported as oncogenes or tumor suppressors in many cancers, including gastric cancer (GC). However, the role and molecular mechanism of miR-3129 in GC is largely unknown. We aimed to explore the function and the underlying molecular mechanism of miR-3129 in GC. Cancer tissues and corresponding adjacent tissues were collected from 50 patients with GC, and the expression of miR-3129 was detected by RT-qPCR. The expression of miR-3129 and pRb in human GC cell line SCG7091 was altered by transient transfection. Thereafter, MTT and flow cytometry assays were used to analyze cell viability and cell cycle. The expression of cyclin E, CDK2, CDK2 inhibitors (p16 and 21), and pRb were detected by RT-qPCR and western blot. A significant up-regulation of miR-3129 was observed in GC tissues compared to adjacent tissues. Overexpression of miR-3129 significantly improved cell viability after 4 days of post-transfection. Flow cytometry assay results showed that the miR-3129 overexpression arrested more SGC7901 cells at S phase. Moreover, overexpression of miR-3129 down-regulated the expression of CDK2 inhibitors while it up-regulated the expression levels of cyclin E, CDK2, and pRb. Interestingly, we found that pRb inhibition reversed the effect of miR-3129 inhibitor on cell proliferation in SGC7901 cells, increased cell viability, reduced cells at G0/1 phase, and modulated the expression of proliferation-related factors. Our results revealed that miR-3129 functioned as an oncogene through positive regulation of pRb and may prove to be a promising option for molecular therapy of GC.

Citing Articles

Prognosis and survival study in patients with gastric adenocarcinoma and its relationship with pRb expression alteration: A retrospective IHC-based study.

Zahir S, Razavi S, SafiDahaj F, Rahmani K, Sadeghinejad-Alamabadi S Health Sci Rep. 2023; 6(7):e1445.

PMID: 37519424 PMC: 10372302. DOI: 10.1002/hsr2.1445.


Enhancer RNA commits osteogenesis via microRNA-3129 expression in human bone marrow-derived mesenchymal stem cells.

Nguyen A, Yamagata K, Iwata S, Trimova G, Zhang T, Shan Y Inflamm Regen. 2022; 42(1):43.

PMID: 36114571 PMC: 9479228. DOI: 10.1186/s41232-022-00228-4.


miR-204-5p Suppress Lymph Node Metastasis via Regulating CXCL12 and CXCR4 in Gastric Cancer.

Zhang J, Xing L, Xu H, Wang K, She J, Shi F J Cancer. 2020; 11(11):3199-3206.

PMID: 32231725 PMC: 7097947. DOI: 10.7150/jca.33273.


miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells.

Wang F J Int Med Res. 2019; 47(2):926-935.

PMID: 30614349 PMC: 6381512. DOI: 10.1177/0300060518817171.

References
1.
Harbour J, Dean D . Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000; 2(4):E65-7. DOI: 10.1038/35008695. View

2.
Munger K, Howley P . Human papillomavirus immortalization and transformation functions. Virus Res. 2002; 89(2):213-28. DOI: 10.1016/s0168-1702(02)00190-9. View

3.
Mraz M, Chen L, Rassenti L, Ghia E, Li H, Jepsen K . miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1. Blood. 2014; 124(1):84-95. PMC: 4125356. DOI: 10.1182/blood-2013-09-527234. View

4.
Wu J, Li G, Yao Y, Wang Z, Sun W, Wang J . MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers. 2014; 20(1):58-63. DOI: 10.3109/1354750X.2014.992812. View

5.
Guarnieri D, DiLeone R . MicroRNAs: a new class of gene regulators. Ann Med. 2008; 40(3):197-208. DOI: 10.1080/07853890701771823. View